Most lately, it has been recognized that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in equivalent places as classical opioid receptors, it binds to a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts like a scavenger and isn't going to activate a 2nd